Previous Article | Next Article ![]()
Journal of Clinical Microbiology, July 1998, p. 2109-2111, Vol. 36, No. 7
Veterinary Medical Research Institute of the
Hungarian Academy of Sciences, Budapest, Hungary
Received 7 November 1997/Returned for modification 4 March
1998/Accepted 7 April 1998
A reference strain (Movár 33/63) of bovine herpesvirus type 4 (BHV-4) was inoculated into 14 different human cell lines and five
primary cell cultures representing various human tissues. BHV-4
replicated in two embryonic lung cell lines, MRC-5 and Wistar-38, and
in a giant-cell glioblastoma cell culture. Cytopathic effect and
intranuclear inclusion bodies were observed in these cells. PCR
detected a 10,000-times-higher level of BHV-4 DNA. Titration of the
supernatant indicated a 100-fold increase of infectious particles.
Since this is the first bovine (human herpesvirus 8 and Epstein-Barr
virus related) herpesvirus which replicates on human cells in vitro,
the danger of possible human BHV-4 infection should not be ignored.
In contrast to other beta- and
gammaherpesviruses, bovine herpesvirus type 4 (BHV-4) replicates in a
wide variety of cell cultures, i.e., established primary cell cultures
of cattle, sheep, goats, dogs, cats, rabbits, pigs, and primary chicken
kidneys (3). Various cell lines of these species are
susceptible to BHV-4. The American reference strain (DN-599) was found
to grow to high titers in mink lung and ferret kidney cells
(14). Crandell feline kidney (CRFK) cells also support
replication of BHV-4 (8). Several species are susceptible to
BHV-4 infection. The virus was previously isolated from cattle
(3), American bison (Bison bison)
(18). African buffalo (Syncerus caffer)
(15), goats (10), and nonruminant species such as
lions (2a) and a cat suffering from urolithiasis
(6). Simian herpesvirus aotus type 2, isolated from the
kidney of an apparently normal owl monkey (Aotus
trivirgatus), was proven to be a BHV-4 strain (4). This monkey isolate replicated in four monkey cell lines (owl monkey kidney
[OMK]; squirrel monkey kidney, intestines, and lung [SMC]; cebus
monkey kidney [CMK]; and African green monkey kidney [Vero]), rabbit kidney (RK) cells, and goat cells (GC), where cytopathic effect
(CPE) and inclusion bodies were observed. No CPE was seen in a primary
culture of whole human embryo cells (2).
To examine the susceptibility of various human cell lines to BHV-4,
105 cells from each type were added to wells of 24-well
tissue culture plates (Greiner, Frickenhausen, Germany). The cells were
maintained in minimal essential medium (Serva, Heidelberg, Germany)
containing NaHCO3 supplemented with 10% fetal calf serum,
0.34 g of L-glutamine (Sigma, St. Louis, Mo.) per
liter, 500,000 IU of penicillin per liter, and 0.5 g of
streptomycin sulfate per liter. Two milliliters of cell culture fluid
was added to each well, and the cells were inoculated with 50 µl of
tissue culture fluid containing 105 PFU of the European
reference strain of BHV-4 (Movár 33/63).
One hundred microliters from one well without cells was immediately
titrated. The rest of the liquid was left to serve as the negative
control for PCR studies, to determine the number of the inoculated
virus particles.
The plates were incubated in a humidified 5% CO2
atmosphere at 37°C for a week, and then the cell-free supernatant was
examined by titration and the whole culture with cells was assayed by
PCR. The cell cultures were monitored daily for CPE.
For the 14 human cell lines, the five primary cell cultures, and the
positive control Madin-Darby bovine kidney (MDBK) cell line, see the
data in Table 1.
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Replication of Bovine Herpesvirus Type 4 in Human Cells In Vitro
![]()
ABSTRACT
Top
Abstract
Text
References
![]()
TEXT
Top
Abstract
Text
References
TABLE 1.
Data on human cell lines and primary cultures included in
the experiments
To titrate the supernatant of the virus-infected cells, after the 7-day-long incubation period 10-fold dilutions of the supernatant were inoculated into dividing MDBK cells and were incubated as described above.
Replication of BHV-4 in human cells was examined by a thymidine kinase nested PCR (5). Limiting (10-fold) dilutions were examined in the PCR to detect the highest dilution which contained at least 1 to 10 particles. The dilutions yielding negative results were retested three times in order to confirm the absence of viral DNA. The plates were frozen and thawed three times, and the DNA was extracted by the phenol-chloroform method (16) with proteinase K (Sigma) digestion (100 µl of the suspension was incubated with 40 µg of proteinase K enzyme at 55°C for 1 h). Supernatants of all types of cell lines, primary cell cultures, and the cell-free control were examined by PCR.
Inoculation of cells was performed twice with all cell lines and cultures, even if the virus did not show any signs of replication, to verify that the cells were not permissive for BHV-4 infection. Where CPE was seen, the inoculation, titration of the supernatant, and PCR studies were repeated three times to confirm the positive result and prove its reproducibility.
CPE was detected on three cell lines, i.e., WI-38, MRC-5, and giant-cell glioblastoma cells (12). CPE appeared on postinoculation day (PID) 3, when scattered round, enlarged cells were observed. By PID 5, the round cells spread to all parts of the cell sheet, and at PID 7, the cells were floating in the supernatant and were not attached to the bottom of the flask.
BHV-4-infected WI-38, MRC-5, and giant-cell glioblastoma cells, where CPE was observed, were stained with hematoxylin-eosin to detect BHV-4-specific intranuclear inclusion bodies (1) (Fig. 1).
|
Titration of the supernatant of these cells showed a 100-fold increase in the number of infectious particles, since the titer rose from 102 to 104 in MRC-5, WI-38, and giant-cell glioblastoma cell lines and to 105 in MDBK cell culture.
The PCR revealed a 104-fold increase in the number of viral
genomes after a weeklong incubation (1 µl of the cell-free control fluid gave a positive result in the PCR assay, while 10
4
µl of the WI-38, MRC-5, and giant-cell glioblastoma lines gave a
positive result).
The data on BHV-4 replication in vitro on human cell lines may be interesting since only some primate herpesviruses, e.g., herpesvirus simiae (B virus), herpesvirus saimiri, and herpesvirus ateles, are known to replicate in human cells (HEp-2 and human foreskin fibroblasts) in vitro (7, 11). Replication of BHV-4 in lung cells is not unexpected, since the lungs play a key role in BHV-4 infections, the virus replicates in vivo and in vitro in tissues and cell lines of the respiratory tract (bovine lung and fetal calf turbinate [10, 13]), and the virus has often been isolated from animals with respiratory illnesses (3, 9).
Heparin-like moieties of the cell surface serve as the initial receptors for BHV-4 (19). Such receptors must be present on human embryonic lung cells, but the receptor may be missing or changed on cell lines originating from adult individuals. The giant-cell glioblastoma culture consisted of mostly undifferentiated cells.
Another factor which is in accordance with virus replication on embryonic tissues is the dependence of BHV-4 replication on S phase of the cell cycle (20). BHV-4 needs dividing cells for effective DNA replication, and all three BHV-4-permissive cell lines were fast growing. Even though this paper contains in vitro data on BHV-4 replication, the danger of possible human infection (especially by consuming raw bovine milk or beef) cannot be ignored.
Since BHV-4 is in the same herpesvirus subgroup as Kaposi's sarcoma herpesvirus (human herpesvirus 8), identification of cells permissive and nonpermissive for BHV-4 infection may provide additional insight into the cell surface receptors utilized by this related human herpesvirus.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by the Hungarian National Research Grant OTKA T 21183.
The cells were kindly provided by János Minárovits and György Berencsi, from the Johan Béla Institution for Public Health, Budapest; József Ongrádi, from the Virology Department of Semmelweis Medical University, Budapest; Ivett Mándy, from the Virology Department, and Judit Deák, from the Department of Clinical Microbiology, of Szentgyörgyi Medical University, Szeged; Zoltán Nagy, from The National Stroke Centre, Budapest; and Ilona Katona, from the National Institute of Neurosurgery, Budapest, Hungary. I am grateful to technician Szilvia Pap for her skilled and reliable assistance throughout the experiment.
| |
FOOTNOTES |
|---|
* Mailing address: Veterinary Medical Research Institute of the Hungarian Academy of Sciences, Budapest, Hungary. Phone: 36-1-252-2455. Fax: 36-1-252-1069. E-mail: Laci{at}novell.vmri.hu.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Augsburger, H. R., and A. E. Metzler. 1989. In vitro growth characteristics of bovine herpesvirus 4 (BHV-4) as revealed by indirect immunofluorescence assay with monoclonal antibodies and polyvalent antisera. Arch. Virol. 104:309-321[Medline]. |
| 2. | Barahona, H. H., L. V. Melendez, N. W. King, M. D. Daniel, C. E. O. Fraser, and A. C. Preville. 1973. Herpesvirus aotus type 2: a new viral agent from owl monkeys (Aotus trivirgatus). J. Infect. Dis. 127:171-178[Medline]. |
| 2a. | Bartha, A. Personal communication. |
| 3. | Bartha, A., M. Juhász, and H. Liebermann. 1966. Isolation of a bovine herpesvirus from calves with respiratory disease and keratoconjunctivitis. Acta Vet. Acad. Sci. Hung. 16:357-358[Medline]. |
| 4. |
Bublot, M.,
J. Dubuisson,
M. F. Van Bressem,
S. Danyi,
P. P. Pastoret, and E. Thiry.
1991.
Antigenic and genomic identity between simian herpesvirus aotus type 2 and bovine herpesvirus type 4.
J. Gen. Virol.
72:715-719 |
| 5. | Egyed, L., A. Ballagi-Pordány, A. Bartha, and S. Belák. 1996. Studies on the in vivo distribution of bovine herpesvirus type 4 in the natural host. J. Clin. Microbiol. 34:1091-1095[Abstract]. |
| 6. |
Fabricant, C. G.,
J. H. Gillespie, and L. Krook.
1971.
Intracellular and extracellular mineral crystal formation induced by viral infection of cell cultures.
Infect. Immun.
3:416-419 |
| 7. | Hilliard, J. K., R. Eberle, S. L. Lipper, R. M. Munoz, and S. A. Weiss. 1987. Herpesvirus simiae (B virus): replication of the virus and identification of viral polypeptides in infected cells. Arch. Virol. 93:185-198[Medline]. |
| 8. | Kruger, J. M., C. A. Osborne, S. M. Goyal, K. A. Pomeroy, and T. D. O'Brien. 1990. Clinicopathologic and pathologic findings of herpesvirus-induced urinary tract infection in conventionally reared cats. Am. J. Vet. Res. 51:1649-1655[Medline]. |
| 9. | Mohanty, S. B., R. C. Hammond, and M. G. Lillie. 1971. A new bovine herpesvirus and its effect on experimentally infected calves. Arch. Gesamte Virusforsch. 33:394-395[Medline]. |
| 10. | Moreno-Lopez, J., M. Goltz, C. Rehbinder, K. V. Valsala, and H. Ludwig. 1989. A bovine herpesvirus (BHV-4) as passenger virus in ethmoidal tumours in Indian cattle. J. Vet. Med. Ser. B 36:481-486. |
| 11. | Mou, S. W., J. K. Hilliard, C. H. Song, and E. Eberle. 1986. Comparison of the primate alphaherpesviruses. I. Characterization of two herpesviruses from spider monkeys and squirrel monkeys and viral polypeptides synthesized in infected cells. Arch. Virol. 91:117-133[Medline]. |
| 12. | Müller, W., F. Slowik, R. Firsching, D. Afra, and P. Sanker. 1987. Contribution to the problem of giant cell astrocytomas. Neurosurg. Rev. 10:213-219[Medline]. |
| 13. |
Osorio, F. A.,
D. L. Rock, and D. E. Reed.
1985.
Studies on the pathogenesis of a bovine cytomegalo-like virus in an experimental host.
J. Gen. Virol.
66:1941-1951 |
| 14. | Peterson, R. B., and S. M. Goyal. 1988. Propagation and quantitation of animal herpesviruses in eight cell culture systems. Comp. Immunol. Microbiol. Infect. Dis. 11:93-98[Medline]. |
| 15. | Rossiter, P. B., I. D. Gumm, D. A. Stagg, P. A. Conrad, S. Mukolwe, F. G. Davies, and H. White. 1984. Isolation of bovine herpesvirus-3 from African buffaloes (Syncerus caffer). Res. Vet. Sci. 46:337-343. |
| 16. | Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 17. |
Sorrentino, V.,
P. Di Francesco,
M. Soria, and G. B. Rossi.
1982.
A human amniotic cell line yielding high titres of human fibroblast interferon.
J. Gen. Virol.
63:509-511 |
| 18. |
Todd, W. J., and J. Storz.
1983.
Morphogenesis of a cytomegalovirus from an American bison affected with malignant catarrhal fever.
J. Gen. Virol.
64:1025-1030 |
| 19. | Vanderplasschen, A., M. Bublot, J. Dubuisson, P. P. Pastoret, and E. Thiry. 1993. Attachment of the gammaherpesvirus bovine herpesvirus 4 is mediated by the interaction of gp8 glycoprotein with heparinlike moieties on the cell surface. Virology 196:232-240[Medline]. |
| 20. | Vanderplasschen, A., M. Goltz, J. Lyaku, C. Benarafa, H. J. Buhk, E. Thiry, and P. P. Pastoret. 1995. The replication in vitro of the gammaherpesvirus bovine herpesvirus 4 is restricted by its DNA synthesis dependence on the S phase of the cell cycle. Virology 213:328-340[Medline]. |
| 21. | Weiss, A. L., R. L. Wiskocil, and J. D. Stobo. 1984. The role of T3 surface molecules in the activation of human T cells: a two-stimulus requirement for IL 2 production reflects events occurring at a pre-translational level. J. Immunol. 133:123-128[Abstract]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|